The APOE ε4 genetic variant is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD) and is increasingly being implicated in other neurodegenerative diseases. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.